About Us
The Nigerian Urban Reproductive Health Initiative Phase 2 (NURHI 2) was designed to shift norms that drive use of modern contraceptives at structural, service delivery, and community levels in Kaduna, Lagos, and Oyo States. The project sought to achieve a 12.5% increase in modern contraceptive prevalence in the three states, contributing to the Nigerian Government’s goal of reaching a national contraceptive prevalence rate of 27% by 2020 … Read More
NURHI Champions Voices
The Nigerian Urban Reproductive Health Initiative Phase 2 (NURHI 2) is the second phase of a ground-breaking 10-year family planning project in Nigeria funded by the Bill & Melinda Gates Foundation and a private philanthropist.
NURHI 2 employed results-oriented advocacy to create a supportive environment for family planning…
The NURHI 2 service delivery strategy focused on improving the quality of and expanding equitable access to family planning services…
Research, monitoring, evaluation and knowledge management supported all NURHI strategies and approaches… READ MORE
NURHI 2 employed a combination of social mobilisation, media campaigns and entertainment education to increase demand for modern contraception…
NURHI 2 integrated a deliberate and innovative focus on adolescents and youth (aged 15-24)…
A Nigeria where supply and demand barriers to contraceptive use are eliminated and family planning becomes a social norm.
To increase contraceptive prevalence rates in Kaduna, Lagos, and Oyo States by 12.5%.
NURHI Phase 1 (2009 – 2015)
Phase 1 of NURHI was implemented in six cities (Federal Capital Territory, Ibadan, Ilorin, Kaduna, Benin and Zaria). According to the 2013 Nigeria Demographic and Health Survey, it contributed to significant increases in contraceptive prevalence in these cities.
NURHI Phase 1 (2009 – 2015)
Phase 1 of NURHI was implemented in six cities (Federal Capital Territory, Ibadan, Ilorin, Kaduna, Benin and Zaria).According to the 2013 Nigeria Demographic and Health Survey, it contributed to significant increases in contraceptive prevalence in these cities.
NURHI Champions Voices